Robert W. Baird Has Lowered Expectations for Owens & Minor (NYSE:OMI) Stock Price

Owens & Minor (NYSE:OMI) had its price objective lowered by Robert W. Baird from $14.00 to $10.00 in a research note published on Tuesday morning,Benzinga reports. The firm currently has a neutral rating on the stock.

OMI has been the topic of several other reports. Barclays cut their target price on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. Citigroup cut their price target on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a report on Tuesday, November 5th. Finally, UBS Group reduced their price target on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $14.92.

Owens & Minor Stock Performance

Shares of OMI stock opened at $6.88 on Tuesday. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09. The firm has a market capitalization of $530.82 million, a price-to-earnings ratio of -10.59, a price-to-earnings-growth ratio of 0.20 and a beta of 0.48. Owens & Minor has a one year low of $6.07 and a one year high of $28.35. The company has a 50 day moving average price of $11.57 and a 200 day moving average price of $13.30.

Institutional Trading of Owens & Minor

A number of hedge funds have recently made changes to their positions in the company. Royce & Associates LP grew its holdings in Owens & Minor by 179.4% during the 3rd quarter. Royce & Associates LP now owns 80,914 shares of the company’s stock valued at $1,270,000 after purchasing an additional 51,955 shares in the last quarter. FMR LLC grew its stake in shares of Owens & Minor by 0.8% during the third quarter. FMR LLC now owns 11,564,624 shares of the company’s stock valued at $181,449,000 after acquiring an additional 90,862 shares in the last quarter. Waldron Private Wealth LLC purchased a new stake in shares of Owens & Minor during the fourth quarter worth about $406,000. JPMorgan Chase & Co. lifted its stake in shares of Owens & Minor by 68.4% in the third quarter. JPMorgan Chase & Co. now owns 376,830 shares of the company’s stock worth $5,912,000 after acquiring an additional 152,999 shares in the last quarter. Finally, Foundry Partners LLC purchased a new position in Owens & Minor in the third quarter valued at about $5,238,000. Hedge funds and other institutional investors own 98.04% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.